about
Poorly differentiated clusters (PDC) in colorectal cancer: what is and ought to be knownTracking the intermediate stages of epithelial-mesenchymal transition in epithelial stem cells and cancerEpithelial-to-mesenchymal plasticity of cancer stem cells: therapeutic targets in hepatocellular carcinomaRisk factors for local recurrence following neoadjuvant chemoradiotherapy for rectal cancersTensile Forces Originating from Cancer Spheroids Facilitate Tumor InvasionValidation of podocalyxin-like protein as a biomarker of poor prognosis in colorectal cancerThe biological complexity of colorectal cancer: insights into biomarkers for early detection and personalized careMolecular and pathogenetic aspects of tumor budding in colorectal cancerInflammation and skeletal metastasisDisturbed expression of E-cadherin, beta-catenin and tight junction proteins in colon carcinoma is unrelated to growth pattern and genetic polymorphisms.CD8/CD45RO T-cell infiltration in endoscopic biopsies of colorectal cancer predicts nodal metastasis and survivalABCG5-positivity in tumor buds is an indicator of poor prognosis in node-negative colorectal cancer patients.Controversies in the pathological assessment of colorectal cancerHigh tumour cannabinoid CB1 receptor immunoreactivity negatively impacts disease-specific survival in stage II microsatellite stable colorectal cancer.Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer.Nonlinear modelling of cancer: bridging the gap between cells and tumoursTumor budding predicts response to anti-EGFR therapies in metastatic colorectal cancer patients.Pancreatic cancer cells enhance the ability of collagen internalization during epithelial-mesenchymal transition.Tumor budding is associated with an increased risk of lymph node metastasis and poor prognosis in superficial esophageal adenocarcinoma.Prognostic value of poorly differentiated clusters in invasive breast cancer.Synergistic effects of combined DNA methyltransferase inhibition and MBD2 depletion on breast cancer cells; MBD2 depletion blocks 5-aza-2'-deoxycytidine-triggered invasivenessQuality assurance in pathology in colorectal cancer screening and diagnosis—European recommendations.Review of histopathological and molecular prognostic features in colorectal cancerThe tumor border configuration of colorectal cancer as a histomorphological prognostic indicator.Tumor budding correlates with poor prognosis and epithelial-mesenchymal transition in tongue squamous cell carcinoma.Tumor budding as a strong prognostic indicator in invasive ampullary adenocarcinomas.Overexpression of podocalyxin-like protein is an independent factor of poor prognosis in colorectal cancer.Accumulation of FOXP3+T-cells in the tumor microenvironment is associated with an epithelial-mesenchymal-transition-type tumor budding phenotype and is an independent prognostic factor in surgically resected pancreatic ductal adenocarcinomaRoles of N-acetylglucosaminyltransferase III in epithelial-to-mesenchymal transition induced by transforming growth factor β1 (TGF-β1) in epithelial cell lines.The Natural History of pT1 Colorectal Cancer.Tumor Budding in Colorectal Carcinoma: Confirmation of Prognostic Significance and Histologic Cutoff in a Population-based Cohort.Decreased miR-320a promotes invasion and metastasis of tumor budding cells in tongue squamous cell carcinoma.Neuron navigator 2 overexpression indicates poor prognosis of colorectal cancer and promotes invasion through the SSH1L/cofilin-1 pathwayHigh-Grade Tumor Budding Stratifies Early-Stage Cervical Cancer with Recurrence RiskTumor budding and recurrence in submucosal invasive colorectal cancers of favorable histology: case reports of two early colorectal cancers with advanced recurrences.Distribution of residual cancer cells in the bowel wall after neoadjuvant chemoradiation in patients with rectal cancer.Tumor budding is a significant indicator of a poor prognosis in lung squamous cell carcinoma patientsTumor budding as a potential histopathological biomarker in colorectal cancer: hype or hope?Microenvironmental interactions and expression of molecular markers associated with epithelial-to-mesenchymal transition in colorectal carcinoma.Drug resistance originating from a TGF-β/FGF-2-driven epithelial-to-mesenchymal transition and its reversion in human lung adenocarcinoma cell lines harboring an EGFR mutation.
P2860
Q26752641-107819F2-B9C7-4E25-B8E7-2222E3B78792Q26829478-9BCCBF90-333B-4F2D-9E6D-1D1D4F695473Q26849546-F90AD7C6-36D2-4C5E-9CD9-0E8093D2E718Q26853016-B14FF485-C38E-48FE-92B5-FA499B983946Q27342759-8E19B49A-B80B-4CD6-BA08-8A70AF273D07Q27496689-8F90640E-CA98-4DD7-A8A5-784AFF8330CBQ28066460-8B9FBEDA-C031-4C00-8404-0E1E24C6C4AFQ28085313-B95BEFBA-785D-4CAE-86B9-737B38C7D4F0Q28396089-04A0E4BB-E0D7-40AE-9565-6AE69FAE26DCQ33327299-AF4130FA-0577-41AE-B3C4-5805777670C7Q33615807-0029EFB0-9491-440B-8EDE-8799EE5E47E1Q33632359-1CCA7A95-5A6F-495F-8D40-CB245D9F7732Q34008807-168C90AC-D02F-4653-9547-C9E1539A35B4Q34013690-6EBD9835-ED3B-4505-A2C1-812D930AED76Q34059673-8BCDBB82-1DED-4213-9CCE-3A924DB781B8Q34090411-33FF5022-E0F3-443F-9ED2-71D0057BF96DQ34200852-CC1EB54C-F827-4A24-B689-151DE3E24BA6Q34336268-35D5FD81-F629-4B80-B1D8-6CEA55732721Q34403203-16F43DDF-E371-41A8-AF18-4CA44C4B8A94Q34409852-CADD7C2E-9A90-4469-B3D5-9312C978665BQ34434924-E7E9D84C-EF68-4D5D-84C7-D46626402DFDQ34467695-BD80EF45-714B-4370-9F38-BB2925028D52Q34657323-D727E023-43F2-4D77-A5D8-7850C84E9093Q34660196-E0E15F53-F0A5-4371-9295-D3DD25423930Q35103412-EC9F6012-1332-4806-9160-79585AC2D0F6Q35186940-E7AD91E4-51EE-4E0B-94CD-538FC1993BC0Q35287580-4C4FE542-7E6C-468A-A969-336AF49C7AE0Q35551974-81A52B92-230C-48FE-8046-8DE6AA614B21Q35956588-8F073FFA-10BF-4F98-B7CA-C0A9781D2CABQ35971375-B0CD1661-E3DD-4979-AFE7-9EA00D140339Q36054317-9AA0B5B7-AC45-4A37-8214-5A37A41283AEQ36119364-F0B8DF28-C64D-4A88-98A9-866128E27B98Q36143888-9C045C0F-C1E8-4E0A-BCA5-74704507C68EQ36197182-3944AAAC-7E81-47F6-A5D1-BEC0C1E7B7BFQ36343525-5540E3D6-D96D-441C-BB5E-B4D11D3963EDQ36358764-B40A64E2-1EA2-43C6-8F74-92277F80D442Q36383278-EFD7BD53-5701-4BBA-AD4F-DC909DE0443AQ36450516-002BE905-BDA6-4D91-8DF9-93F60C9D880FQ36464398-816D0803-22D6-4D35-8356-D1B939DF1A36Q36734197-98390132-EC65-4F53-B0CD-3300B9081A9C
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Tumour budding in colorectal carcinoma.
@ast
Tumour budding in colorectal carcinoma.
@en
type
label
Tumour budding in colorectal carcinoma.
@ast
Tumour budding in colorectal carcinoma.
@en
prefLabel
Tumour budding in colorectal carcinoma.
@ast
Tumour budding in colorectal carcinoma.
@en
P2860
P1433
P1476
Tumour budding in colorectal carcinoma.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2559.2006.02551.X
P577
2007-01-01T00:00:00Z